Chris Bahl
@cdbahl.com
Thanks for the fun conversation Ingmar Schuster, and for the opportunity to share more about what we're building at @aiproteins.com!
youtu.be/7O0s5AY46U0
youtu.be/7O0s5AY46U0
Chris Bahl on the Conundrum of Biotech Platforms
YouTube video by Provolut
youtu.be
November 21, 2025 at 8:18 PM
Thanks for the fun conversation Ingmar Schuster, and for the opportunity to share more about what we're building at @aiproteins.com!
youtu.be/7O0s5AY46U0
youtu.be/7O0s5AY46U0
I appreciate all the congratulations for our Series A! I also want to make sure we don't forget an important truth
Funding is not the finish line.
We're grateful for the resources we have, and my promise is that we'll continue to do everything in our power to make a difference
Funding is not the finish line.
We're grateful for the resources we have, and my promise is that we'll continue to do everything in our power to make a difference
AI Proteins has closed a $41.5 million Series A financing to accelerate the development of de novo #miniproteins! The round was led by Mission BioCapital and SANTÉ, with robust participation from existing investors.
See the official press release for details:
www.businesswire.com/news/home/20...
See the official press release for details:
www.businesswire.com/news/home/20...
November 20, 2025 at 8:03 PM
I appreciate all the congratulations for our Series A! I also want to make sure we don't forget an important truth
Funding is not the finish line.
We're grateful for the resources we have, and my promise is that we'll continue to do everything in our power to make a difference
Funding is not the finish line.
We're grateful for the resources we have, and my promise is that we'll continue to do everything in our power to make a difference
The next chapter for AI Proteins @aiproteins.com is officially underway! I'm absolutely delighted to share that we’ve closed a $41.5M Series A led by Mission BioCapital and Santé Ventures.
endpoints.news/boston-biote...
endpoints.news/boston-biote...
Exclusive: AI Proteins raises $42M Series A, and will launch miniproteins into hub-and-spoke model
AI Proteins raises $42M Series A for minibinder drug development, led by Mission BioCapital & Santé Ventures. CEO Chris Bahl aims to target TNFR1 with first candidate.
endpoints.news
November 18, 2025 at 3:55 PM
The next chapter for AI Proteins @aiproteins.com is officially underway! I'm absolutely delighted to share that we’ve closed a $41.5M Series A led by Mission BioCapital and Santé Ventures.
endpoints.news/boston-biote...
endpoints.news/boston-biote...
Reposted by Chris Bahl
Join us in Room 181, Building 68 @mit.edu on October 22nd 2025 @ 7pm EDT to see @grocklin.bsky.social present a mind blowing amount of data and learn what becomes possible at this scale
"Predicting protein folding stability and aggregation propensity using large-scale experiments"
bpdmc.org
"Predicting protein folding stability and aggregation propensity using large-scale experiments"
bpdmc.org
schedule
introduction and membership
Boston Protein Design and Modeling Club (BPDMC) is a community of computational protein engineers and modelers from both academia and industry. While we are based in Boston...
bpdmc.org
October 17, 2025 at 8:27 PM
Join us in Room 181, Building 68 @mit.edu on October 22nd 2025 @ 7pm EDT to see @grocklin.bsky.social present a mind blowing amount of data and learn what becomes possible at this scale
"Predicting protein folding stability and aggregation propensity using large-scale experiments"
bpdmc.org
"Predicting protein folding stability and aggregation propensity using large-scale experiments"
bpdmc.org
We're looking for a mass spec expert to join our team at @aiproteins.com! This position is ideal for a freshly-minted PhD grad (or someone who will graduate within the next 6 months or less), or a rockstar scientist who earned their skills on the job in biotech
We're #hiring a Scientist in Mass Spectrometry!
Apply today or share this post with your network: www.linkedin.com/jobs/view/42...
(ignore what linkedin says - the search is still open)
Interested? Please email your CV to: [email protected]
Apply today or share this post with your network: www.linkedin.com/jobs/view/42...
(ignore what linkedin says - the search is still open)
Interested? Please email your CV to: [email protected]
AI Proteins hiring Scientist in Mass Spectrometry Miniproteins and Bioconjugates in Greater Boston | LinkedIn
Posted 8:20:30 PM. The Company:AI Proteins is a Boston-based biotechnology company focused on the de novo design and…See this and similar jobs on LinkedIn.
www.linkedin.com
September 3, 2025 at 5:47 PM
We're looking for a mass spec expert to join our team at @aiproteins.com! This position is ideal for a freshly-minted PhD grad (or someone who will graduate within the next 6 months or less), or a rockstar scientist who earned their skills on the job in biotech
Reposted by Chris Bahl
🎥 Neste videocast produzido junto do @ieausp.bsky.social, tive uma conversa inspiradora com o Anderson Soares (UFG), @alexandre-cf.bsky.social e o @cdbahl.com sobre como a IA está moldando o futuro da biologia e da saúde humana. Assista aqui 👉 www.youtube.com/watch?v=qQbZ...
Inteligência Artificial Aplicada às Ciências da Vida
YouTube video by Instituto de Estudos Avançados da USP
www.youtube.com
September 1, 2025 at 4:00 AM
🎥 Neste videocast produzido junto do @ieausp.bsky.social, tive uma conversa inspiradora com o Anderson Soares (UFG), @alexandre-cf.bsky.social e o @cdbahl.com sobre como a IA está moldando o futuro da biologia e da saúde humana. Assista aqui 👉 www.youtube.com/watch?v=qQbZ...
Reposted by Chris Bahl
Congratulations to Dr. James Bowman on his promotion to Chief Technology Officer!
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
www.businesswire.com
August 26, 2025 at 2:39 PM
Congratulations to Dr. James Bowman on his promotion to Chief Technology Officer!
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
I am overjoyed to announce that James Bowman has been promoted to Chief Technology Officer at @aiproteins.com!
🧵👇
🧵👇
August 26, 2025 at 2:17 PM
I am overjoyed to announce that James Bowman has been promoted to Chief Technology Officer at @aiproteins.com!
🧵👇
🧵👇
This was a lot of fun - thanks so much @yossefbaidi.bsky.social and @fang-xie.bsky.social for the great conversation, and for your passion and excitement for biotech and entrepreneurship!
During this episode, @fang-xie.bsky.social and I interview @cdbahl.com, co-founder and CEO of @aiproteins.com. We discuss with Chris his interest in protein science and how he started his academic lab at the @ipiproteins.bsky.social.
July 12, 2025 at 4:10 PM
This was a lot of fun - thanks so much @yossefbaidi.bsky.social and @fang-xie.bsky.social for the great conversation, and for your passion and excitement for biotech and entrepreneurship!
Reposted by Chris Bahl
Super excited to share a new preprint from our lab on design of small-molecule binding proteins using neural networks! The paper has a bit of everything. A new graph neural network, new design algorithms, and experimental validation. www.biorxiv.org/content/10.1...
🧵🧪
🧵🧪
Zero-shot design of drug-binding proteins via neural selection-expansion
Computational design of molecular recognition remains challenging despite advances in deep learning. The design of proteins that bind to small molecules has been particularly difficult because it requ...
www.biorxiv.org
April 28, 2025 at 3:22 PM
Super excited to share a new preprint from our lab on design of small-molecule binding proteins using neural networks! The paper has a bit of everything. A new graph neural network, new design algorithms, and experimental validation. www.biorxiv.org/content/10.1...
🧵🧪
🧵🧪
Reposted by Chris Bahl
#IPISeminar alert 🔔 Friday at 2 p.m. ET, Chris Bahl of AI Proteins will share the challenges of incorporating #artificialintelligence into #proteindesign & the impact reimagined #miniproteins can have on therapeutics. Join us through the QR code or follow the Zoom link on our calendar! rb.gy/xcee9l
May 1, 2025 at 2:08 PM
#IPISeminar alert 🔔 Friday at 2 p.m. ET, Chris Bahl of AI Proteins will share the challenges of incorporating #artificialintelligence into #proteindesign & the impact reimagined #miniproteins can have on therapeutics. Join us through the QR code or follow the Zoom link on our calendar! rb.gy/xcee9l
It was an honor to speak from the main stage at TED last week about our work at AI Proteins
Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics
Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics
April 15, 2025 at 4:26 PM
It was an honor to speak from the main stage at TED last week about our work at AI Proteins
Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics
Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics
Big news to share! Phil Brandish has joined our team and will lead drug development efforts at AI Proteins. Phil is a rockstar, with a stellar track record and years of experience successfully bringing molecules into the clinic at Merck and Bicycle Therapeutics.
Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team!
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
AI Proteins Appoints Philip E. Brandish, PhD as Chief Development Officer
AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel miniprotein therapeutics, today announced the appointment of
www.businesswire.com
February 12, 2025 at 4:51 PM
Big news to share! Phil Brandish has joined our team and will lead drug development efforts at AI Proteins. Phil is a rockstar, with a stellar track record and years of experience successfully bringing molecules into the clinic at Merck and Bicycle Therapeutics.
I’m excited to share that I am now the CEO of AI Proteins @aiproteins.bsky.social! I’m grateful to continue leading this exceptional team as we build upon the strong foundation that we’ve established since launching the company in 2021.
www.businesswire.com/news/home/20...
🧵👇
www.businesswire.com/news/home/20...
🧵👇
AI Proteins Appoints Founder Dr. Chris Bahl as Chief Executive Officer; Company to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week
AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel protein therapeutics, announces the appointment of its found
www.businesswire.com
January 7, 2025 at 2:15 PM
I’m excited to share that I am now the CEO of AI Proteins @aiproteins.bsky.social! I’m grateful to continue leading this exceptional team as we build upon the strong foundation that we’ve established since launching the company in 2021.
www.businesswire.com/news/home/20...
🧵👇
www.businesswire.com/news/home/20...
🧵👇
So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @aiproteins.bsky.social colors
December 20, 2024 at 3:17 AM
So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @aiproteins.bsky.social colors
Mireia Solà Colom gave an incredible seminar at @bpdmc.bsky.social last week, and I'm very excited for her to share some details about what we've built at @aiproteins.bsky.social and how well our #miniproteins perform as therapeutics
for the folks who weren't able to join for the brilliant presentation by Mireia Solà Colom last week to cap off our 2024 seminar series, you can check out the recording 👇
youtu.be/e6oZgGWjD_0
youtu.be/e6oZgGWjD_0
De novo design of miniprotein-based natural killer cell engagers
YouTube video by Boston Protein Design and Modeling Club
youtu.be
December 17, 2024 at 9:21 PM
Mireia Solà Colom gave an incredible seminar at @bpdmc.bsky.social last week, and I'm very excited for her to share some details about what we've built at @aiproteins.bsky.social and how well our #miniproteins perform as therapeutics
So excited for my postdoc mentor David Baker giving his Nobel Prize lecture in Stockholm!!
December 8, 2024 at 10:19 AM
So excited for my postdoc mentor David Baker giving his Nobel Prize lecture in Stockholm!!
Reposted by Chris Bahl
Today, several #NobelPrize Laureates arrive in Stockholm, warmly welcomed by Hans Ellegren. Here we see David Baker stepping off the plane at Arlanda.
This week is packed with inspiration, press conferences and lectures, so stay tuned! 🌟
@uofwa.bsky.social @hhmi.bsky.social
#Science #AcademicSky
This week is packed with inspiration, press conferences and lectures, so stay tuned! 🌟
@uofwa.bsky.social @hhmi.bsky.social
#Science #AcademicSky
December 5, 2024 at 12:48 PM
Today, several #NobelPrize Laureates arrive in Stockholm, warmly welcomed by Hans Ellegren. Here we see David Baker stepping off the plane at Arlanda.
This week is packed with inspiration, press conferences and lectures, so stay tuned! 🌟
@uofwa.bsky.social @hhmi.bsky.social
#Science #AcademicSky
This week is packed with inspiration, press conferences and lectures, so stay tuned! 🌟
@uofwa.bsky.social @hhmi.bsky.social
#Science #AcademicSky
Reposted by Chris Bahl
Exciting times at @aiproteins.bsky.social ! We are getting so close to see our drugs helping patients!
www.fiercebiotech.com/biotech/bris...
www.fiercebiotech.com/biotech/bris...
Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M
Bristol Myers Squibb has
www.fiercebiotech.com
December 3, 2024 at 7:48 PM
Exciting times at @aiproteins.bsky.social ! We are getting so close to see our drugs helping patients!
www.fiercebiotech.com/biotech/bris...
www.fiercebiotech.com/biotech/bris...
Reposted by Chris Bahl
Reposted by Chris Bahl
You can read more about our exciting new collaboration with Bristol Myers Squibb in this coverage from Fierce Biotech
www.fiercebiotech.com/biotech/bris...
www.fiercebiotech.com/biotech/bris...
Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M
Bristol Myers Squibb has
www.fiercebiotech.com
December 3, 2024 at 6:58 PM
You can read more about our exciting new collaboration with Bristol Myers Squibb in this coverage from Fierce Biotech
www.fiercebiotech.com/biotech/bris...
www.fiercebiotech.com/biotech/bris...
Reposted by Chris Bahl
AI Proteins is excited to partner with @bms-news.bsky.social to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that
www.businesswire.com
December 3, 2024 at 5:30 PM
AI Proteins is excited to partner with @bms-news.bsky.social to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes
www.businesswire.com/news/home/20...
www.businesswire.com/news/home/20...
We've got some very exciting news to share!
businesswire.com/news/home/20...
and here's a 🧵 about the journey from academia to
@aiproteins.bsky.social
businesswire.com/news/home/20...
and here's a 🧵 about the journey from academia to
@aiproteins.bsky.social
AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M
AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that
businesswire.com
December 3, 2024 at 2:49 PM
We've got some very exciting news to share!
businesswire.com/news/home/20...
and here's a 🧵 about the journey from academia to
@aiproteins.bsky.social
businesswire.com/news/home/20...
and here's a 🧵 about the journey from academia to
@aiproteins.bsky.social
Reposted by Chris Bahl
There's just one meeting left in 2024, and we have a spectacular seminar by Mireia Solà Colom lined up for you! Join us at 7pm in Room 181, Building 68, MIT on Wednesday, December 11th.
"De novo design of miniprotein-based natural killer cell engagers"
See you there & Happy Thanksgiving!
bpdmc.org
"De novo design of miniprotein-based natural killer cell engagers"
See you there & Happy Thanksgiving!
bpdmc.org
schedule
introduction and membership
Boston Protein Design and Modeling Club (BPDMC) is a community of computational protein engineers and modelers from both academia and industry. While we are based in Boston...
bpdmc.org
November 22, 2024 at 10:48 PM
There's just one meeting left in 2024, and we have a spectacular seminar by Mireia Solà Colom lined up for you! Join us at 7pm in Room 181, Building 68, MIT on Wednesday, December 11th.
"De novo design of miniprotein-based natural killer cell engagers"
See you there & Happy Thanksgiving!
bpdmc.org
"De novo design of miniprotein-based natural killer cell engagers"
See you there & Happy Thanksgiving!
bpdmc.org